As Integrated Care Seaside Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1550 Fremont Blvd, Seaside, CA 93955 Phone: 831-755-4545 |
Seaside Family Health Ctr Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1156 Fremont Blvd, Seaside, CA 93955 Phone: 831-899-8100 Fax: 831-899-8105 |
Seaside Community Health Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 1130 Fremont Blvd, Suite 210-b, Seaside, CA 93955 Phone: 831-728-8250 Fax: 831-707-2777 |
Seaside Family Health Ctr Family Medicine Medicare: Medicare Enrolled Practice Location: 1156 Fremont Blvd, Seaside, CA 93955 Phone: 831-899-8100 Fax: 831-899-8105 |
Cecilia Loleng General Practice Medicare: Not Enrolled in Medicare Practice Location: 1780 Fremont Blvd, H, Seaside, CA 93955 Phone: 831-394-0615 Fax: 831-394-4580 |
Planned Parenthood Mar Monte, Inc Clinic/Center - Community Health Medicare: Not Enrolled in Medicare Practice Location: 625 Hilby Ave, Seaside, CA 93955 Phone: 831-394-1691 Fax: 831-394-1870 |
News Archive
Scientists from RIKEN in Japan have discovered that acrolein—a toxic substance produced in cells during times of oxidative stress—in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases.
As recently as April, Obamacare was going to be the silver bullet for Republicans in this year's midterm elections. The leader of conservative advocacy group Americans for Prosperity said his plan was to make Obamacare "the No. 1 issue in the country." Senate Minority Leader Mitch McConnell, R-Ky., declared that the law would be "a huge disaster in 2014" and the deciding factor in November. Well, that was then. Now, three weeks from Election Day, some GOP challengers trying to knock off Democratic incumbent senators have scaled back their anti-Obamacare ads in favor of new targets such as the economy and national security (10/13).
SNM applauds the U.S. Food and Drug Administration's (FDA) recent decision to approve the radioimmunotherapy (RIT) drug, Zevalin, as a front-line treatment of non-Hodgkin's lymphoma (NHL).
"The study was designed to test if IL-1ra is safe in stroke patients and showed promising results," said Professor Rothwell, a world-renowned neuroscientist based in the University's Faculty of Life Sciences.
Researchers at the University of California Los Angeles (UCLA) have found that a second molecular pathway may need to be blocked to prevent malignant cells from creating new blood vessels [angiogenesis]. A study of patients with pancreatic cancer showed that CXCL5 may be a key molecule in the angiogenesis switch—the point at which cells stop being normal and start producing blood vessels that feed malignancy.
› Verified 4 days ago